Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
FDA accepts NDA for Tenpoint Therapeutic’s brimochol PF for presbyopia
Published on June 3, 2025
The PDUFA date for brimochol PF is January 28, 2026.
Continue reading on website
Other news
HPV Patients at Increased Risk for Glaucoma
June 3, 2025
Chronic inflammation, endothelial dysfunction and oxidative stress may be the mechanisms connecting HPV infection to glaucoma, but authors of a recent study suggest further research is needed. Photo: Justin Cole, OD, and Jarett Mazzarella, OD. Click image to enlarge. Previous studies have shown that inflammation plays a role in both glaucoma and human papillomavirus (HPV), b
What do we lose if we do not value residencies?
June 3, 2025
Diane Russo, OD, MPH, MBA, FAAO, Dipl AAO PH, and Nicole Quinn, OD, FAAO, highlight the continued importance of residencies in optometric practices.
FDA accepts NDA for Tenpoint Therapeutic’s brimochol PF for presbyopia | Edcetera - Optometry